Literature DB >> 25878246

Caspase-dependent Proteolysis of Human Ribonucleotide Reductase Small Subunits R2 and p53R2 during Apoptosis.

Ali Tebbi1, Olivier Guittet2, Karine Tuphile2, Aimeric Cabrié2, Michel Lepoivre3.   

Abstract

Ribonucleotide reductase (RnR) is a key enzyme synthesizing deoxyribonucleotides for DNA replication and repair. In mammals, the R1 catalytic subunit forms an active complex with either one of the two small subunits R2 and p53R2. Expression of R2 is S phase-specific and required for DNA replication. The p53R2 protein is expressed throughout the cell cycle and in quiescent cells where it provides dNTPs for mitochondrial DNA synthesis. Participation of R2 and p53R2 in DNA repair has also been suggested. In this study, we investigated the fate of the RnR subunits during apoptosis. The p53R2 protein was cleaved in a caspase-dependent manner in K-562 cells treated with inhibitors of the Bcr-Abl oncogenic kinase and in HeLa 229 cells incubated with TNF-α and cycloheximide. The cleavage site was mapped between Asp(342) and Asn(343). Caspase attack released a C-terminal p53R2 peptide of nine residues containing the conserved heptapeptide essential for R1 binding. As a consequence, the cleaved p53R2 protein was inactive. In vitro, purified caspase-3 and -8 could release the C-terminal tail of p53R2. Knocking down these caspases, but not caspase-2, -7, and -10, also inhibited p53R2 cleavage in cells committed to die via the extrinsic death receptor pathway. The R2 subunit was subjected to caspase- and proteasome-dependent proteolysis, which was prevented by siRNA targeting caspase-8. Knocking down caspase-3 was ineffective. Protein R1 was not subjected to degradation. Adding deoxyribonucleosides to restore dNTP pools transiently protected cells from apoptosis. These data identify RnR activity as a prosurvival function inactivated by proteolysis during apoptosis.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  apoptosis; caspase; nucleoside/nucleotide biosynthesis; protein degradation; ribonucleotide reductase

Mesh:

Substances:

Year:  2015        PMID: 25878246      PMCID: PMC4447979          DOI: 10.1074/jbc.M115.649640

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Mammalian caspases: structure, activation, substrates, and functions during apoptosis.

Authors:  W C Earnshaw; L M Martins; S H Kaufmann
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 2.  Oligopeptide inhibition of class I ribonucleotide reductases.

Authors:  Barry S Cooperman
Journal:  Biopolymers       Date:  2003       Impact factor: 2.505

3.  ApoptoProteomics, an integrated database for analysis of proteomics data obtained from apoptotic cells.

Authors:  Magnus Ø Arntzen; Bernd Thiede
Journal:  Mol Cell Proteomics       Date:  2011-11-08       Impact factor: 5.911

4.  A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.

Authors:  H Tanaka; H Arakawa; T Yamaguchi; K Shiraishi; S Fukuda; K Matsui; Y Takei; Y Nakamura
Journal:  Nature       Date:  2000-03-02       Impact factor: 49.962

5.  TAp73 induction by nitric oxide: regulation by checkpoint kinase 1 (CHK1) and protection against apoptosis.

Authors:  Ali Tebbi; Olivier Guittet; Marie-Hélène Cottet; Marie-Françoise Vesin; Michel Lepoivre
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

6.  Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization.

Authors:  James Wesley Fairman; Sanath Ranjan Wijerathna; Md Faiz Ahmad; Hai Xu; Ryo Nakano; Shalini Jha; Jay Prendergast; R Martin Welin; Susanne Flodin; Annette Roos; Pär Nordlund; Zongli Li; Thomas Walz; Chris Godfrey Dealwis
Journal:  Nat Struct Mol Biol       Date:  2011-02-20       Impact factor: 15.369

Review 7.  The intersection between DNA damage response and cell death pathways.

Authors:  S Nowsheen; E S Yang
Journal:  Exp Oncol       Date:  2012-10

8.  Mouse ribonucleotide reductase R2 protein: a new target for anaphase-promoting complex-Cdh1-mediated proteolysis.

Authors:  Anna Lena Chabes; Cathie M Pfleger; Marc W Kirschner; Lars Thelander
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

9.  2.6 A X-ray crystal structure of human p53R2, a p53-inducible ribonucleotide reductase .

Authors:  Peter Smith; Bingsen Zhou; Nam Ho; Yate-Ching Yuan; Leila Su; Shiou-Chuan Tsai; Yun Yen
Journal:  Biochemistry       Date:  2009-11-24       Impact factor: 3.162

10.  Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair.

Authors:  Vincenzo D'Angiolella; Valerio Donato; Frances M Forrester; Yeon-Tae Jeong; Claudia Pellacani; Yasusei Kudo; Anita Saraf; Laurence Florens; Michael P Washburn; Michele Pagano
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

View more
  4 in total

Review 1.  Still no Rest for the Reductases: Ribonucleotide Reductase (RNR) Structure and Function: An Update.

Authors:  Marcus J C Long; Phillippe Ly; Yimon Aye
Journal:  Subcell Biochem       Date:  2022

2.  Proteome profiling of different rat brain regions reveals the modulatory effect of prolonged maternal separation on proteins involved in cell death-related processes.

Authors:  Zdenka Drastichova; Vladimir Rudajev; Gergely Pallag; Jiri Novotny
Journal:  Biol Res       Date:  2021-02-08       Impact factor: 5.612

3.  RRM2B Is Frequently Amplified Across Multiple Tumor Types: Implications for DNA Repair, Cellular Survival, and Cancer Therapy.

Authors:  Waleed Iqbal; Elena V Demidova; Samantha Serrao; Taha ValizadehAslani; Gail Rosen; Sanjeevani Arora
Journal:  Front Genet       Date:  2021-03-12       Impact factor: 4.599

4.  Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer.

Authors:  Miriana Hijaz; Soumen Das; Ismail Mert; Ankur Gupta; Zaid Al-Wahab; Calvin Tebbe; Sajad Dar; Jasdeep Chhina; Shailendra Giri; Adnan Munkarah; Sudipta Seal; Ramandeep Rattan
Journal:  BMC Cancer       Date:  2016-03-15       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.